Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors

Proteasome inhibitors (PIs) have markedly improved response rates as well as the survival of multiple myeloma (MM) patients over the past decade and have become an important foundation in the treatment of MM patients. Unfortunately, the majority of patients either relapses or becomes refractory to p...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Control Release
Autori principali: Hu, Hangting, Petrosyan, Armen, Osna, Natalia A., Liu, Tong, Olou, Appolinaire A., Alakhova, Daria Y., Singh, Pankaj K., Kabanov, Alexander V., Faber, Edward A., Bronich, Tatiana K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822276/
https://ncbi.nlm.nih.gov/pubmed/31121280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.05.026
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi